Evrofarma (LTS:0EEK) Beta: -0.0779 (As of Jun. 25, 2026)


What is Evrofarma Beta?

Evrofarma LTS:0EEK Beta is -0.0779 as of Jun. 25, 2026.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Evrofarma's Beta is -0.0779.

Evrofarma  (LTS:0EEK) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Evrofarma Beta Related Terms

Evrofarma Beta Historical Data

* Premium members only.

The historical data trend for Evrofarma's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evrofarma Beta Chart

Evrofarma Annual Data
Trend
Beta

Evrofarma Quarterly Data
Beta

LTS:0EEK vs FAMI, VATE, CYAN: Beta Comparison

For the Packaged Foods subindustry, Evrofarma's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evrofarma Beta vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Evrofarma's Beta distribution charts can be found below:

* The bar in red indicates where Evrofarma's Beta falls into.


Evrofarma Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.0779 mean?
Evrofarma (LTS:0EEK) has a Beta of -0.0779 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Evrofarma and its competitors.
Is Evrofarma's Beta too high?
Evrofarma's current Beta is -0.0779.
How does Evrofarma's Beta compare to FAMI and VATE?
Evrofarma's Beta of -0.0779 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Consumer Packaged Goods company?
A good Beta depends on the Consumer Packaged Goods industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Evrofarma and its competitors. Evrofarma's current Beta is -0.0779. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evrofarma stock overvalued right now?
Evrofarma (LTS:0EEK) has a current Beta of -0.0779. The current Beta is -0.0779. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Evrofarma (LTS:0EEK), the current Beta is -0.0779 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evrofarma Business Description

Address 1st km Didimoticho-Orestiada, Didimoticho, GRC, 68300
Evrofarma SA through its subsidiary Campus SA produces milk and dairy products such as yogurt and cheese. The company also trades animal feed and animals such as cows, goats and sheep. Its products include Yellow Cheese, Anthotiro, Telemes, Cow's yogurt, Goat's cheese and Feta DPO.